Search

Your search keyword '"Epithelioid Hemangioma"' showing total 3 results
Start Over Descriptor "Epithelioid Hemangioma" Journal case reports in oncology
3 results on '"Epithelioid Hemangioma"'

1. Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol

Author

Sam Broida, Nickolas Reimer, and William L. Read

Subjects
Epithelioid hemangioma, Vascular neoplasm, Propranolol, Bone tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Epithelioid hemangioma is an uncommon benign vascular neoplasm which can arise in bone. Resection is generally curative, but occasionally lesions recur and recurrence after surgery can be morbid and destructive. Recent case reports have described the effective use of oral propranolol to control recurrent epithelioid hemangioma of the orbit. We report the case of a 26 year old man with recurrent aggressive osseous epithelioid hemangioma in the pelvis of which has been controlled for over a year with outpatient propranolol monotherapy.

Published
2019
Full Text
View/download PDF

2. Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol.

Author

Broida, Sam, Reimer, Nickolas, and Read, William L.

Subjects
*PELVIC bones, *HEMANGIOMAS, *PROPRANOLOL, *BENIGN tumors, *OLDER men, *TROPHOBLASTIC tumors
Abstract

Epithelioid hemangioma is an uncommon benign vascular neoplasm which can arise in bone. Resection is generally curative, but occasionally lesions recur and recurrence after surgery can be morbid and destructive. Recent case reports have described the effective use of oral propranolol to control recurrent epithelioid hemangioma of the orbit. We report the case of a 26 year old man with recurrent aggressive osseous epithelioid hemangioma in the pelvis of which has been controlled for over a year with outpatient propranolol monotherapy. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

3. Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy

Author

Wafeek Alguayn, Rachel Gibbs, Nir Peled, Yael Refaely, Yulia Dudnik, Walid Shalata, Samueli Benzion, Daniel Levin, Tawfeek A Kian, Mahmuod A Salah, Konstantin Lavrenkov, Amir Korngreen, Alexander Yakobson, Waleed Kian, and Laila C. Roisman

Subjects
0301 basic medicine, Surgical resection, medicine.medical_specialty, Salvage therapy, rib epithelioid hemangioma, Case Report, lcsh:RC254-282, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Symptom relief, medicine, pazopanib, Epithelioid hemangioendothelioma, Epithelioid Hemangioma, business.industry, Mediastinum, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030104 developmental biology, medicine.anatomical_structure, Vascular Tumors, epithelioid hemangioendothelioma, Oncology, 030220 oncology & carcinogenesis, Radiology, business, medicine.drug
Abstract

Epithelioid hemangioma (EH) and epithelioid hemangioendothelioma (EHE) are both rare vascular tumors. EH tumors are often benign while EHE tumors have moderate malignant potential. Here, we present three unique cases at Soroka Medical Center, two featuring EH of the bone and one presenting EHE of the mediastinum. Each case demonstrates distinct treatment challenges due to the rarity of both diseases and lack of established guidelines. We propose three treatment approaches including pazopanib for salvage therapy of EH of the bone and minimally invasive surgical resection which in these cases lead to complete symptom relief and tumor stabilization upheld over time with close follow-up.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results